SNDL Reports First Quarter 2026 Financial and Operational Results

1 hour ago 3

Author of the article:

GlobeNewswire

Published Apr 29, 2026

19 minute read

Article content

The Company Maintains Strong Liquidity and Advances Strategic Priorities and Profit-Enhancement Initiatives

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

EDMONTON, Alberta, April 29, 2026 (GLOBE NEWSWIRE) — SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) reported its financial and operational results for the first quarter ended March 31, 2026. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.

Article content

Article content

SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com.

Article content

Article content

The Company will hold a conference call and webcast presentation at 10:00 a.m. EDT (8:00 a.m. MDT) on Wednesday, April 29, 2026. The conference call details can be found below.

Article content

By signing up you consent to receive the above newsletter from Postmedia Network Inc.

Article content

MANAGEMENT HIGHLIGHTS

Article content

  • Net revenue for the first quarter of 2026 was $195.9 million, representing a -4.4% decrease compared with the same period of the prior year, driven by market headwinds in both Liquor and Cannabis segments.
  • Gross profit of $52.8 million for the first quarter of 2026, represents a decline of $(3.8) million, or -6.8%, compared to the same period of the prior year, driven by lower revenue across all segments and inventory adjustments and one-time costs in Cannabis Operations.
  • Gross margin (1) of 27.0% in the first quarter of 2026 represents a reduction of -0.7% compared to the same period of the prior year, driven by Cannabis Operations, partially offset by margin expansion in both Liquor and Cannabis Retail segments.
  • Operating Loss of $(9.1) million for the first quarter of 2026, representing an improvement of $2.9 million compared to the same period of the prior year, driven by the absence of prior-year equity-accounted investees valuation reductions and restructuring-related charges, which more than offset the decline in gross profit. Excluding restructuring-related charges, Adjusted Operating Loss totaled $(8.9) million in the first quarter of 2026, a $0.1 million improvement compared with the same period of the prior year.
  • Cash flow was negative by $(26.7) million in the first quarter of 2026, partly driven by cash outflows of $9.6 million related to share repurchases, $6.6 million associated with changes in long‑term investments, and a $2.9 million payment for the acquisition of five Cost Cannabis retail stores.
  • Free cash flow (1) was negative $(7.6) million in the first quarter of 2026, driven by income statement losses and inventory build-ups within Cannabis Operations.

Article content

Article content

“Beyond the normal seasonality that impacts the first quarter each year, Q1 2026 was particularly challenging, driven primarily by market softness across our business segments and operating territories,” said Zach George, Chief Executive Officer of SNDL. “While remaining focused on our strategic priorities and anticipating an improvement in the cannabis market in the second half of the year, we are not standing still. We are proactively adjusting our commercial execution and cost structure to reflect the reality of current market conditions.”

Article content

Some of the initiatives advanced during the first quarter include:

Article content

  • Jeeter Contract: Ahead of the official April 2026 launch, SNDL assumed exclusive Canadian production and commercialization of Jeeter, a leading U.S. cannabis brand, enhancing its positioning in the premium pre-roll category.
  • Profit-enhancement initiatives: In parallel with adjustments to commercial execution to mitigate softer market demand, the Company is deploying several initiatives expected to contribute approximately $20 million of incremental operating income over the remainder of the year.
  • SunStream restructuring progress: As U.S. cannabis rescheduling gains momentum, the restructuring of the Parallel and Skymint investments continues to advance toward completion, with only a limited number of remaining requirements outstanding.
  • Share buybacks: During the first quarter of 2026, the Company repurchased 4.5 million common shares for cancellation, bringing the total numbers of shares repurchased since the fourth quarter of 2024 to 15.1 million.

Advertisement 1

Advertisement 2

Article content

“With $213.4 million of unrestricted cash and no debt as of March 31, 2026, and exposure across the Canadian, U.S., and European markets, we are uniquely positioned to deploy capital across both organic and inorganic opportunities to further enhance our portfolio and accelerate growth. We are confident that, as current market conditions continue to challenge existing operators, attractive opportunities may emerge in the short to mid‑term. More than ever, disciplined capital allocation remains a key priority for our management team, alongside continued execution on efficiency initiatives and profit‑enhancement actions,” concluded Zach George.

Article content

TOTAL COMPANY HIGHLIGHTS

Article content

 Three months ended March 31 
($000s)2026 2025 % Change 
IFRS Financial Measures      
Net revenue 195,906  204,914  -4.4%
Gross profit 52,812  56,641  -6.8%
Operating income (loss) (9,114) (12,053) 24.4%
Change in cash and cash equivalents (26,697) 2,508  -1164.5%
       
Non-IFRS Financial Measures(1)      
Gross margin 27.0% 27.6% -0.7pp
Adjusted operating income (loss) (8,942) (9,031) 1.0%
Free cash flow (7,591) (1,090) -596.4%

Article content

Article content

(1) Gross Margin is a supplementary financial measure calculated by dividing Gross Profit by Net Revenue. Adjusted operating income (loss) and Free Cash Flow are specified financial measures that do not have a standardized meanings prescribed by IFRS and therefore may not be comparable to similar measures reported by other companies. See “Non-IFRS Measures” section below for further information.

Article content

BUSINESS SEGMENT HIGHLIGHTS

Article content

SNDL operates and reports its business through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. Additionally, a consolidated total for Cannabis is presented, encompassing the combined results of the two Cannabis segments, along with the revenue elimination associated with the Cannabis Operations sales to the provincial boards that are expected to be subsequently repurchased by the Company’s licensed retail subsidiaries for resale. Corporate and shared service expenses are reported as “Corporate”.

Article content

 Three months ended March 31 
($000s)2026 2025(2) % Change 
Net Revenue      
Cannabis Retail 77,345  77,540  -0.3%
Cannabis Operations 29,432  34,319  -14.2%
Intersegment Eliminations (14,954) (16,417) 8.9%
Total Cannabis 91,823  95,442  -3.8%
Liquor Retail 104,083  109,472  -4.9%
Investments     0.0%
Total 195,906  204,914  -4.4%
       
Operating Income      
Cannabis Retail 1,116  1,327  -15.9%
Cannabis Operations (6,942) (6,171) -12.5%
Total Cannabis (5,826) (4,844) -20.3%
Liquor Retail (3,160) (2,417) -30.7%
Investments 2,038  (1,601) 227.3%
Corporate (2,166) (3,191) 32.1%
Total (9,114) (12,053) 24.4%
       
Adjusted Operating Income      
Cannabis Retail 1,116  1,327  -15.9%
Cannabis Operations (6,942) (3,276) -111.9%
Total Cannabis (5,826) (1,949) -198.9%
Liquor Retail (3,160) (2,417) -30.7%
Investments 2,038  (1,601) 227.3%
Corporate (1,994) (3,064) 34.9%
Total (8,942) (9,031) 1.0%

Article content

Article content

(2) In 2026, the Company began allocating applicable direct and indirect overhead costs from the corporate segment to each individual operating segment all categorized within general and administrative expenses. The Company has recast the comparative period to illustrate the impact of these allocations had they been done during the prior period, as documented in the condensed interim Financial Statements.

Article content

Liquor Retail

Article content

SNDL is Canada’s largest private sector liquor retailer, operating at April 28, 2026 in 167 locations, predominantly in Alberta, under its three retail banners: “Wine and Beyond” (15), “Liquor Depot” (19), and “Ace Liquor” (133).

Article content

 Three months ended March 31 
($000s)2026 2025 % Change 
Net revenue 104,083  109,472  -4.9%
Gross profit 26,658  27,803  -4.1%
Gross margin 25.6% 25.4% 0.2pp
Operating income (3,160) (2,417) -30.7%
Adjusted operating income (3,160) (2,417) -30.7%
          

Article content

  • Net revenue for Liquor Retail continued to decline in the first quarter of 2026, as market demand softness persisted and impacted same-store sales(3), which decreased by -6.1% in the period compared to the same period of the prior year.
  • Operating income declined, driven by lower revenue, partially offset by gross margin improvements, including increased penetration of private‑label offerings at accretive margins, as well as cost optimization and in‑store productivity initiatives.

Article content

(3) Same-store sales is a specified financial measure that does not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measures used by other companies. See “Non-IFRS Measures” section below for further information.

Article content

Cannabis Retail

Article content

SNDL is one of Canada’s largest private-sector cannabis retailer, operating at April 28, 2026 in 193 locations under its three retail banners: “Value Buds” (127), “Spiritleaf” (61, of which 4 are corporate stores and 57 are franchise stores), and “Cost Cannabis” (5). The Company’s Cannabis Retail strategy is based on several pillars, including the quality of its store locations, its range of products, and the unique experiences provided to customers. Using data and insights from a large volume of monthly transactions enables SNDL to leverage technology and analytics to inform and improve its retail strategy.

Article content

 Three months ended March 31 
($000s)2026 2025 % Change 
Net revenue 77,345  77,540  -0.3%
Gross profit 20,352  19,627  3.7%
Gross margin 26.3% 25.3% 1.0pp
Operating income 1,116  1,327  -15.9%
Adjusted operating income 1,116  1,327  -15.9%
          

Article content

Article content

  • Net revenue for Cannabis Retail declined slightly in the first quarter compared with the same period of the prior year, driven by a same‑store sales decline of -2.5%, partially offset by new store openings and Value Buds store conversions. New stores included the integration of five Cost Cannabis locations in Alberta and Saskatchewan.
  • Operating income also declined slightly compared with the same period of the prior year due to $1 million of un-adjusted one‑time charges incurred during the quarter, despite improvements in gross margin and SG&A cost efficiency. Gross margin expanded by one percentage point, supported by price increases, improved promotional effectiveness, and favorable product mix management.

Article content

Cannabis Operations

Article content

SNDL has a diverse brand portfolio from value to premium, emphasizing premium inhalable formats and a full suite of 2.0 products. With enhanced procurement capabilities and plans to continue evolving toward a cost-effective cultivation and manufacturing operation, the Cannabis Operations segment is a key enabler of SNDL’s vertical integration strategy.

Article content

Article content

 Three months ended March 31 
($000s)2026 2025 % Change 
Net revenue 29,432  34,319  -14.2%
Gross profit 5,802  9,211  -37.0%
Gross margin 19.7% 26.8% -7.1pp
Operating income (loss) (6,942) (6,171) -12.5%
Adjusted operating income (loss) (6,942) (3,276) -111.9%
          

Article content

  • Cannabis Operations experienced a larger relative decline in revenue, driven by overall softening market demand, destocking activity, and temporary adjustments in business-to-business order phasing. These declines were partially offset by growth in international sales, which increased from $1.8 million in the first quarter of 2025 to $3.5 million in the first quarter of 2026.
  • Operating income declined compared with the same period in the prior year, driven by gross margin compression and one‑time, unadjusted charges. The gross margin decline was primarily attributable to inventory adjustments and under‑absorption resulting from lower production volumes. One‑time, unadjusted charges included an incremental write‑down related to the idle Stellarton facility.

Article content

Investments

Article content

  • As of March 31, 2026, the Company has deployed capital to a portfolio of cannabis-related investments with a carrying value of $410.1 million, including $395.4 million to SunStream Bancorp Inc. (“SunStream”). This carrying value was increased by $12.5 million during the first quarter of 2026, primarily due to an increase in the USD to CAD exchange rate from 1.3706 on December 31, 2025 to 1.3939 on March 31, 2026.
  • The previously disclosed restructuring process relating to Skymint continues. On April 1, 2026, the Michigan Supreme Court has agreed to hear oral argument on applications for leave to appeal. The Court has not reached a decision on the merits. Timing and outcomes remain uncertain and are subject to court process and other factors.
  • The previously disclosed restructuring process relating to Parallel continues. On February 4, 2025, the Florida Department of Health approved the transfer of Parallel’s license, representing an important milestone in completing Parallel’s restructuring process. In December 2025, a settlement was reached resolving the final remaining litigation, and SNDL currently expects the strict foreclosure process to close in Q3 2026, subject to completion of remaining steps, satisfaction of applicable conditions, and any required approvals.
  • The investment portfolio generated a positive operating income of $2.0 million in the first quarter of 2026, primarily driven by interests earned from our cash accounts.
  • On April 23, 2026, the DOJ and DEA issued an order placing FDA-approved cannabis products and state-regulated medical cannabis in Schedule III, while launching an expedited process to reschedule all cannabis from Schedule I. This move is expected to eliminate 280E tax burdens, expand research, improve regulation, and enhance access to capital, strengthening the industry outlook, with direct relevance to SNDL given its exposure to core US medical markets through its SunStream credit exposure.

Article content

Equity Position

Article content

  • $623.6 million of unrestricted cash, marketable securities and investments, including investments in equity-accounted investees, and no outstanding debt at March 31, 2026, resulting in a net book value of $1.1 billion.
  • The board of directors of the Company has approved the renewal of its share repurchase program upon the expiry on November 20, 2025.
  • For the three months ended March 31, 2026, the Company purchased for cancellation 4,453,358 common shares at a weighted average price, excluding commissions, of US$1.56 per share. SNDL will continue to evaluate opportunities to utilize the program to the extent that management believes it is in the best interest of SNDL’s shareholders. As a reminder, since the fourth quarter of 2024 the Company has repurchased 15,055,627 common shares for cancellation.

Article content

This press release is intended to be read in conjunction with the Company’s condensed consolidated interim financial statements and the notes thereto for the three months ended March 31, 2026, and the accompanying Management’s Discussion and Analysis. These documents are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov/edgar.shtml. 

Article content

Article content

CONFERENCE
CALL

Article content

The Company will hold a conference call and webcast presentation at 10:00 a.m. EDT (8:00 a.m. MDT) on Wednesday, April 29, 2026.

Article content

WEBCAST ACCESS
To access the live webcast of the call, please visit the following link:
https://edge.media-server.com/mmc/p/9eyekwcv 

Article content

REPLAY

Article content

Article content

ABOUT SNDL INC. 

Article content

SNDL Inc. (NASDAQ: SNDL, CSE: SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis companies and the largest private-sector liquor and cannabis retailer in Canada, with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf and Cost Cannabis. With products available in licensed cannabis retail locations nationally, SNDL’s consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future and Bhang Chocolate. SNDL’s investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the North American cannabis industry. For more information, please visit www.sndl.comFor more information: 
Tomas Bottger
Investor Relations, SNDL Inc. 
O: 1.587.327.2017 
E: [email protected]

Article content

Article content

Forward-Looking Information Cautionary Statement 
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”), including, but not limited to, statements regarding the Company’s operational goals, plans and key priorities, the Company’s ability to deploy capital and the expected benefits thereof, expectations related to the Jeeter contract, the growth opportunities available to SNDL and the expected benefits thereof, expectations with respect to the 1CM transaction, including the satisfaction of certain regulatory approvals, the progress of the Sunstream restructurings, expectations with respect to the Skymint and Parallel restructuring processes, SNDL’s corporate restructuring program, including the timing to conclude the restructuring and expected benefits thereof, the expected benefits of the enterprise resource planning (“ERP”) system consolidation, SNDL’s ability to recover the senior secured notes held in Cannabist, the potential impact of reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act, the Company’s retail strategy, and any other potential forms of shareholder value creation. Forward-looking statements are frequently characterized by words such as “aim”, “anticipate”, “assume”, “believe”, “contemplate”, “continue”, “could”, “due”, “estimate”, “expect”, “goal”, “intend”, “may”, “objective”, “plan”, “predict”, “potential”, “positioned”, “pioneer”, “seek”, “should”, “target”, “will”, “would”, and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the Company’s business and the industry in which it operates and management’s beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond its control. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see “Risk Factors” in the Company’s annual information form dated March 11, 2026, and the risk factors included in our other public disclosure documents for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. 

Article content

Condensed Consolidated Interim Statement of Loss and Comprehensive Loss
(Expressed in thousands of Canadian dollars, except per share amounts)
    
  Three months ended
March 31
 
  2026  2025 
Net revenue  195,906   204,914 
Cost of sales  143,094   148,273 
Gross profit  52,812   56,641 
       
Investment income  1,537   2,856 
Share of profit (loss) of equity-accounted investees  501   (4,457)
       
General and administrative  46,607   46,359 
Sales and marketing  4,009   3,767 
Depreciation and amortization  12,855   13,228 
Share-based compensation  616   1,388 
Restructuring costs  172   326 
Asset (reversal) impairment, net  (178)  1,984 
Other income  (81)   
Research and development  4   100 
Gain on disposition of assets  (40)  (59)
Operating loss  (9,114)  (12,053)
       
Other expenses, net  (2,294)  (2,654)
Loss before income tax  (11,408)  (14,707)
Income tax recovery  1,497    
Net loss  (9,911)  (14,707)
       
Equity-accounted investees – share of other comprehensive income (loss)  5,013   (348)
Investments at fair value through other comprehensive income (“FVOCI”) – change in fair value  (1,292)  (5,230)
Comprehensive loss  (6,190)  (20,285)
       

Article content

Article content

Condensed Consolidated Interim Statement of Financial Position
(Expressed in thousands of Canadian dollars)
     
As atMarch 31,
2026
 December 31,
2025
 
     
Assets    
Current assets    
Cash and cash equivalents 213,404  252,243 
Restricted cash 20,124  20,081 
Marketable securities 139  84 
Accounts receivable 29,059  27,643 
Biological assets 2,969  3,120 
Inventory 134,982  126,877 
Prepaid expenses and deposits 15,158  15,566 
Investments 362  484 
Assets held for sale 746  746 
Net investment in subleases 2,877  2,775 
  419,820  449,619 
Non-current assets    
Long-term deposits and receivables 2,508  4,526 
Right of use assets 136,852  138,353 
Property, plant and equipment 149,398  151,900 
Net investment in subleases 11,244  11,643 
Intangible assets 57,824  58,520 
Investments 14,322  11,574 
Equity-accounted investees 395,411  385,534 
Goodwill 127,260  124,248 
Total assets 1,314,639  1,335,917 
     
Liabilities    
Current liabilities    
Accounts payable and accrued liabilities 51,799  56,747 
Lease liabilities 34,990  35,462 
  86,789  92,209 
Non-current liabilities    
Lease liabilities 133,381  134,471 
Other liabilities 6,925  8,041 
Total liabilities 227,095  234,721 
     
Shareholders’ equity    
Share capital 2,274,393  2,310,398 
Warrants 306  306 
Contributed surplus 53,089  54,038 
Accumulated deficit (1,282,860) (1,302,441)
Accumulated other comprehensive income (“AOCI”) 42,616  38,895 
Total shareholders’ equity 1,087,544  1,101,196 
Total liabilities and shareholders’ equity 1,314,639  1,335,917 
       

Article content

Article content

Condensed Consolidated Interim Statement of Cash Flows
(Expressed in thousands of Canadian dollars)
 
  Three months ended
March 31
 
  2026  2025 
Cash provided by (used in):      
Operating activities      
Net loss for the period  (9,911)  (14,707)
Adjustments for:      
Income tax recovery  (1,497)   
Interest and fee income  (1,482)  (2,856)
Change in fair value of biological assets  (46)  (1,447)
Change in fair value of inventory sold  230   336 
Share-based compensation  616   1,388 
Depreciation and amortization  14,116   14,187 
Gain on disposition of assets  (40)  (59)
Inventory impairment and obsolescence  1,446   591 
Finance costs, net  2,062   1,690 
Change in estimate of fair value of derivative warrants     (12)
Unrealized foreign exchange (gain) loss  (299)  13 
Asset (reversal) impairment, net  (178)  1,984 
Share of (profit) loss of equity-accounted investees  (501)  4,457 
Unrealized gain on marketable securities  (206)   
Additions to marketable securities  151    
Interest received  1,361   2,936 
Exercise of cash-settled deferred share units  (474)   
Change in non-cash working capital  (1,867)  (713)
Net cash provided by operating activities  3,481   7,788 
Investing activities      
Additions to property, plant and equipment  (2,638)  (1,588)
Additions to investments  (4,032)  (8,997)
Principal payments from investments  116   26,907 
Capital (contributions) distributions from equity-accounted investees  (2,866)  719 
Proceeds from disposal of property, plant and equipment  43   113 
Acquisitions  (2,900)   
Change in non-cash working capital  911   18 
Net cash (used in) provided by investing activities  (11,366)  17,172 
Financing activities      
Payments on lease liabilities, net  (10,056)  (7,512)
Repurchase of common shares  (9,575)  (15,031)
Change in non-cash working capital  819   91 
Net cash used in financing activities  (18,812)  (22,452)
Change in cash and cash equivalents  (26,697)  2,508 
Adjustment on initial application of amendments to IFRS 9 on January 1, 2026  (12,142)   
Cash and cash equivalents, beginning of period  252,243   218,359 
Cash and cash equivalents, end of period  213,404   220,867 
         

Article content

NON-IFRS MEASURES

Article content

Certain specified financial measures in this news release are non-IFRS measures. These terms are not defined by IFRS and, therefore, may not be comparable to similar measures reported by other companies. These non-IFRS financial measures should not be considered in isolation or as an alternative for or superior to measures of performance prepared in accordance with IFRS. These measures are presented and described in order to provide shareholders and potential investors with additional measures in understanding the Company’s operating results in the same manner as the management team.

Article content

ADJUSTED OPERATING INCOME (LOSS)
Adjusted operating income (loss) is a non-IFRS financial measure which the Company uses to evaluate its operating performance in a similar manner to its management team. The Company defines adjusted operating income (loss) as operating income (loss) less restructuring costs (recovery), goodwill and intangible asset impairments and asset impairments triggered by restructuring activities.

Article content

The following tables reconcile adjusted to un-adjusted operating income (loss) for the periods noted.

Article content

Article content

($000s)Cannabis
Retail
 Cannabis
Operations
 Cannabis
Total
 Liquor
Retail
 Investments Corporate Total 
Three months ended March 31, 2026 
Operating income (loss) 1,116  (6,942) (5,826) (3,160) 2,038  (2,166) (9,114)
Adjustments:              
Restructuring costs           172  172 
Adjusted operating income (loss) 1,116  (6,942) (5,826) (3,160) 2,038  (1,994) (8,942)

Article content

($000s)Cannabis
Retail
 Cannabis
Operations
 Cannabis
Total
 Liquor
Retail
 Investments Corporate Total 
Three months ended March 31, 2025 
Operating income (loss) 1,327  (6,171) (4,844) (2,417) (1,601) (3,191) (12,053)
Adjustments:              
Restructuring costs   199  199      127  326 
Impairments triggered by restructuring   2,696  2,696        2,696 
Adjusted operating income (loss) 1,327  (3,276) (1,949) (2,417) (1,601) (3,064) (9,031)
                      

Article content

GROSS MARGIN
Gross margin is a supplementary financial measure calculated as gross profit divided by net revenue for the periods presented. This measure evaluates the underlying profitability of our operations and provides useful information about the Company’s ability to price products effectively, manage input costs, drive operating efficiencies, and compare results across periods and business segments

Article content

Article content

FREE CASH FLOW

Free cash flow is a non-IFRS financial measure which the Company uses to evaluate its financial performance, providing information which management believes to be useful in understanding and evaluating the Company’s ability to generate positive cash flows as it removes cash used for non-operational items. The Company defines free cash flow as the total change in cash and cash equivalents less cash used for common share repurchases, dividends (if any), changes to debt instruments, changes to long-term investments, net cash used for acquisitions plus cash provided by dispositions (if any).

Article content

The following table reconciles free cash flow to change in cash and cash equivalents for the periods noted.

Article content

  Three months ended
March 31
 
($000s) 2026  2025 
Change in cash and cash equivalents  (26,697)  2,508 
Adjustments:      
Repurchase of common shares  9,575   15,031 
Changes to long-term investments  6,631   (18,629)
Acquisitions, net of cash acquired  2,900    
Free cash flow  (7,591)  (1,090)
         

Article content

SAME-STORE SALES
Same store sales is a non-IFRS financial measure which the Company uses to evaluate its financial performance in its retail segments. Same store sales provides information which management believes to be useful to investors, analysts and others in understanding and evaluating the Company’s sales trends excluding the effect of the opening and closure of stores.

Article content

Same store sales refers to the revenue generated by the Company’s existing retail locations during the current and prior comparison periods.

Article content

ADJUSTED EBITDA
Adjusted EBITDA is a non-IFRS financial measure which the Company uses to evaluate its operating performance. Adjusted EBITDA provides information to investors, analysts, and others to aid in understanding and evaluating the Company’s operating results. The Company defines adjusted EBITDA as net earnings (loss) before inventory and biological assets fair value and impairment adjustments, share of (gain) loss of equity-accounted investees, depreciation and amortization, share-based compensation expense, restructuring costs, asset impairment, gain or loss on disposal of property, other expenses, net, income tax expense (recovery) and excluding non-recurring items including ERP implementation costs and litigation settlements, net of recoveries.

Article content

  Three months ended
March 31
 
($000s) 2026  2025 
Net earnings (loss)  (9,911)  (14,707)
Adjustments:      
Inventory and biological assets fair value and impairment adjustments  1,630   (520)
Share of (gain) loss of equity-accounted investees  (501)  4,457 
Depreciation and amortization  12,855   13,228 
Share-based compensation  616   1,388 
Restructuring costs  172   326 
Asset impairment  (178)  1,984 
Gain on disposition of PP&E  (40)  (59)
Other expenses, net  2,294   2,654 
Income tax recovery  (1,497)   
Non-recurring items  387   206 
Adjusted EBITDA  5,827   8,957 

Article content

Article content

Article content

Article content

Article content

Article content

Read Entire Article